Click here to get full coverage on TRDA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

TRDA Financials: Income Statement, Balance Sheet & Cash Flow  Stock Titan

TRDA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Click here to get full coverage on HC Wainwright Issues Positive Forecast for TRDA Earnings - MarketBeat

HC Wainwright Issues Positive Forecast for TRDA Earnings  MarketBeat

HC Wainwright Issues Positive Forecast for TRDA Earnings - MarketBeat

Click here to get full coverage on TRDA: Four clinical readouts and pipeline expansion set up a pivotal 2026, driven by EEV technology - TradingView

TRDA: Four clinical readouts and pipeline expansion set up a pivotal 2026, driven by EEV technology  TradingView

TRDA: Four clinical readouts and pipeline expansion set up a pivotal 2026, driven by EEV technology - TradingView

Click here to get full coverage on The Technical Signals Behind (TRDA) That Institutions Follow - Stock Traders Daily

The Technical Signals Behind (TRDA) That Institutions Follow  Stock Traders Daily

The Technical Signals Behind (TRDA) That Institutions Follow - Stock Traders Daily

Click here to get full coverage on Entrada Therapeutics (TRDA) Quarterly Revenue Slump Tests Bullish Growth Narratives - simplywall.st

Entrada Therapeutics (TRDA) Quarterly Revenue Slump Tests Bullish Growth Narratives  simplywall.st

Entrada Therapeutics (TRDA) Quarterly Revenue Slump Tests Bullish Growth Narratives - simplywall.st

Click here to get full coverage on Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline - Yahoo Finance

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline  Yahoo Finance

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline - Yahoo Finance

Click here to get full coverage on New Analyst Forecast: $TRDA Given $20 Price Target - Quiver Quantitative

New Analyst Forecast: $TRDA Given $20 Price Target  Quiver Quantitative

New Analyst Forecast: $TRDA Given $20 Price Target - Quiver Quantitative

Click here to get full coverage on Earnings Summary: Entrada Therapeutics Q4 - Benzinga

Earnings Summary: Entrada Therapeutics Q4  Benzinga

Earnings Summary: Entrada Therapeutics Q4 - Benzinga

Click here to get full coverage on Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Potential Upside of 67.57% Could Attract Investors - DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Potential Upside of 67.57% Could Attract Investors  DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Potential Upside of 67.57% Could Attract Investors - DirectorsTalk Interviews

Click here to get full coverage on Oppenheimer Maintains Entrada Therapeutics(TRDA.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛

Oppenheimer Maintains Entrada Therapeutics(TRDA.US) With Buy Rating, Maintains Target Price $21  富途牛牛

Oppenheimer Maintains Entrada Therapeutics(TRDA.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛

Click here to get full coverage on Earnings Summary: Entrada Therapeutics Q4 - Sahm

Earnings Summary: Entrada Therapeutics Q4  Sahm

Earnings Summary: Entrada Therapeutics Q4 - Sahm

Click here to get full coverage on Entrada Therapeutics: Soft Q3 Earnings, But Builds Momentum Toward 2026 Readouts - Seeking Alpha

Entrada Therapeutics: Soft Q3 Earnings, But Builds Momentum Toward 2026 Readouts  Seeking Alpha

Entrada Therapeutics: Soft Q3 Earnings, But Builds Momentum Toward 2026 Readouts - Seeking Alpha

Click here to get full coverage on Entrada Therapeutics (NASDAQ:TRDA) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Entrada Therapeutics (NASDAQ:TRDA) Stock Rating Upgraded by Wall Street Zen  MarketBeat

Entrada Therapeutics (NASDAQ:TRDA) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Click here to get full coverage on Entrada Therapeutics (NASDAQ: TRDA) maps DMD, DM1 and ocular drug pipeline - Stock Titan

Entrada Therapeutics (NASDAQ: TRDA) maps DMD, DM1 and ocular drug pipeline  Stock Titan

Entrada Therapeutics (NASDAQ: TRDA) maps DMD, DM1 and ocular drug pipeline - Stock Titan

Click here to get full coverage on Entrada Therapeutics, Inc. (NASDAQ:TRDA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - simplywall.st

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report  simplywall.st

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - simplywall.st

Click here to get full coverage on Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Misses Revenue Estimates  Yahoo Finance

Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Click here to get full coverage on Entrada Therapeutics (TRDA) swings to 2025 loss while advancing DMD pipeline - Stock Titan

Entrada Therapeutics (TRDA) swings to 2025 loss while advancing DMD pipeline  Stock Titan

Entrada Therapeutics (TRDA) swings to 2025 loss while advancing DMD pipeline - Stock Titan

Click here to get full coverage on Entrada Therapeutics (NASDAQ:TRDA) Posts Earnings Results, Beats Estimates By $0.38 EPS - MarketBeat

Entrada Therapeutics (NASDAQ:TRDA) Posts Earnings Results, Beats Estimates By $0.38 EPS  MarketBeat

Entrada Therapeutics (NASDAQ:TRDA) Posts Earnings Results, Beats Estimates By $0.38 EPS - MarketBeat

Click here to get full coverage on Entrada Therapeutics (TRDA) to Release Earnings on Thursday - MarketBeat

Entrada Therapeutics (TRDA) to Release Earnings on Thursday  MarketBeat

Entrada Therapeutics (TRDA) to Release Earnings on Thursday - MarketBeat

Click here to get full coverage on Entrada Therapeutics, Inc. (NASDAQ:TRDA) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Given Consensus Recommendation of "Hold" by Brokerages  MarketBeat

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Click here to get full coverage on Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring A 105.99% Potential Upside - DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring A 105.99% Potential Upside  DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring A 105.99% Potential Upside - DirectorsTalk Interviews

Click here to get full coverage on $TRDA stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

$TRDA stock is up 8% today. Here's what we see in our data.  Quiver Quantitative

$TRDA stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Entrada Therapeutics Q4 net loss and EPS beat expectations - TradingView

Entrada Therapeutics Q4 net loss and EPS beat expectations  TradingView

Entrada Therapeutics Q4 net loss and EPS beat expectations - TradingView

Click here to get full coverage on Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  The Manila Times

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Click here to get full coverage on Tennessee Rental Dealers Honor RTO Trio At Membership Meeting - rtohq.org

Tennessee Rental Dealers Honor RTO Trio At Membership Meeting  rtohq.org

Tennessee Rental Dealers Honor RTO Trio At Membership Meeting - rtohq.org

Click here to get full coverage on Entrada Therapeutics, Inc. (NASDAQ:TRDA) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Analysts Are Cutting Their Estimates: Here's What You Need To Know  Yahoo Finance

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance

Click here to get full coverage on Entrada Therapeutics, Inc. SEC 10-K Report - TradingView

Entrada Therapeutics, Inc. SEC 10-K Report  TradingView

Entrada Therapeutics, Inc. SEC 10-K Report - TradingView

Click here to get full coverage on New RNA-based drugs advance for muscular dystrophy and inherited blindness - Stock Titan

New RNA-based drugs advance for muscular dystrophy and inherited blindness  Stock Titan

New RNA-based drugs advance for muscular dystrophy and inherited blindness - Stock Titan

Click here to get full coverage on Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring The 166.57% Potential Upside - DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring The 166.57% Potential Upside  DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring The 166.57% Potential Upside - DirectorsTalk Interviews

Click here to get full coverage on 2025 Tennessee Rental Dealers Association (TRDA) Annual Meeting - rtohq.org

2025 Tennessee Rental Dealers Association (TRDA) Annual Meeting  rtohq.org

2025 Tennessee Rental Dealers Association (TRDA) Annual Meeting - rtohq.org

Click here to get full coverage on Entrada Therapeutics, Inc. (TRDA) Stock Analysis: A 55.81% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: A 55.81% Potential Upside in the Biotech Sector  DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: A 55.81% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Click here to get full coverage on Entrada Therapeutics Awards Nearly 24,000 RSUs in Latest Employee Compensation Plan - Stock Titan

Entrada Therapeutics Awards Nearly 24,000 RSUs in Latest Employee Compensation Plan  Stock Titan

Entrada Therapeutics Awards Nearly 24,000 RSUs in Latest Employee Compensation Plan - Stock Titan

Click here to get full coverage on TRDA Winners Celebration 2025 - Graduate Studies - Trinity College Dublin

TRDA Winners Celebration 2025 - Graduate Studies  Trinity College Dublin

TRDA Winners Celebration 2025 - Graduate Studies - Trinity College Dublin

Click here to get full coverage on This Olema Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga

This Olema Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday  Benzinga

This Olema Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga

Click here to get full coverage on Entrada Therapeutics Eyes 2026 Trial Data With Cash Runway Into 2027 - RTTNews

Entrada Therapeutics Eyes 2026 Trial Data With Cash Runway Into 2027  RTTNews

Entrada Therapeutics Eyes 2026 Trial Data With Cash Runway Into 2027 - RTTNews

Click here to get full coverage on PhD Opportunity - Trinity East - Graduate Studies - Trinity College Dublin

PhD Opportunity - Trinity East - Graduate Studies  Trinity College Dublin

PhD Opportunity - Trinity East - Graduate Studies - Trinity College Dublin

Click here to get full coverage on Entrada Therapeutics highlights RNA pipeline progress and outlook - TipRanks

Entrada Therapeutics highlights RNA pipeline progress and outlook  TipRanks

Entrada Therapeutics highlights RNA pipeline progress and outlook - TipRanks

Click here to get full coverage on Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates - Investing.com India

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates  Investing.com India

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates - Investing.com India

Click here to get full coverage on IRS Establishes New Voluntary Tip Reporting Program - Tax Notes

IRS Establishes New Voluntary Tip Reporting Program  Tax Notes

IRS Establishes New Voluntary Tip Reporting Program - Tax Notes

Click here to get full coverage on Poco F8 Pro appears together with Redmi Note 15 Pro 4G in TRDA - Gizmochina

Poco F8 Pro appears together with Redmi Note 15 Pro 4G in TRDA  Gizmochina

Poco F8 Pro appears together with Redmi Note 15 Pro 4G in TRDA - Gizmochina

Click here to get full coverage on Vivo V60 India Launch Teased; Reportedly Spotted on TRDA Certification Site - Gadgets 360

Vivo V60 India Launch Teased; Reportedly Spotted on TRDA Certification Site  Gadgets 360

Vivo V60 India Launch Teased; Reportedly Spotted on TRDA Certification Site - Gadgets 360

Click here to get full coverage on TRDA - Entrada Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

TRDA - Entrada Therapeutics, Inc. Latest Stock News & Market Updates  Stock Titan

TRDA - Entrada Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Entrada (TRDA) Down on FDA Maintaining Clinical Hold on DMD Drug - Yahoo Finance

Entrada (TRDA) Down on FDA Maintaining Clinical Hold on DMD Drug  Yahoo Finance

Entrada (TRDA) Down on FDA Maintaining Clinical Hold on DMD Drug - Yahoo Finance

Click here to get full coverage on Entrada Therapeutics: A Complicated Tale (NASDAQ:TRDA) - Seeking Alpha

Entrada Therapeutics: A Complicated Tale (NASDAQ:TRDA)  Seeking Alpha

Entrada Therapeutics: A Complicated Tale (NASDAQ:TRDA) - Seeking Alpha

Click here to get full coverage on Entrada Therapeutics: Early Stage But Interesting (NASDAQ:TRDA) - Seeking Alpha

Entrada Therapeutics: Early Stage But Interesting (NASDAQ:TRDA)  Seeking Alpha

Entrada Therapeutics: Early Stage But Interesting (NASDAQ:TRDA) - Seeking Alpha

Click here to get full coverage on IRS Releases Revised TRAC Agreement for Food and Beverage Industry - Tax Notes

IRS Releases Revised TRAC Agreement for Food and Beverage Industry  Tax Notes

IRS Releases Revised TRAC Agreement for Food and Beverage Industry - Tax Notes

Click here to get full coverage on PI Only Winners 2024 2025 - Graduate Studies - Trinity College Dublin

PI Only Winners 2024 2025 - Graduate Studies  Trinity College Dublin

PI Only Winners 2024 2025 - Graduate Studies - Trinity College Dublin

Click here to get full coverage on PI Only Winners 2023 2024 - Graduate Studies - Trinity College Dublin

PI Only Winners 2023 2024 - Graduate Studies  Trinity College Dublin

PI Only Winners 2023 2024 - Graduate Studies - Trinity College Dublin

Click here to get full coverage on News: #Tigray business community calls on federal government to suspend income tax enforcement amid severe regional economic strain Tigray business community has called for the immediate suspension of the Income Tax Amendment Proclamation 1395/ - facebook.com

News: #Tigray business community calls on federal government to suspend income tax enforcement amid severe regional economic strain Tigray business community has called for the immediate suspension of the Income Tax Amendment Proclamation 1395/  facebook.com

News: #Tigray business community calls on federal government to suspend income tax enforcement amid severe regional economic strain Tigray business community has called for the immediate suspension of the Income Tax Amendment Proclamation 1395/ - facebook.com

Click here to get full coverage on TRDA IPO News - Rare disease biotech Entrada Therapeutics files for a $100 million IPO - renaissancecapital.com

TRDA IPO News - Rare disease biotech Entrada Therapeutics files for a $100 million IPO  renaissancecapital.com

TRDA IPO News - Rare disease biotech Entrada Therapeutics files for a $100 million IPO - renaissancecapital.com

Click here to get full coverage on Council talks TRDA budget, hires admin - Tahlequah Daily Press

Council talks TRDA budget, hires admin  Tahlequah Daily Press

Council talks TRDA budget, hires admin - Tahlequah Daily Press

Click here to get full coverage on New advocacy group aims to develop cohesive concussion guidelines across all sporting codes - Trinity College Dublin

New advocacy group aims to develop cohesive concussion guidelines across all sporting codes  Trinity College Dublin

New advocacy group aims to develop cohesive concussion guidelines across all sporting codes - Trinity College Dublin

Click here to get full coverage on Entrada Therapeutics: Cash-Rich Innovator With Asymmetric Upside - Seeking Alpha

Entrada Therapeutics: Cash-Rich Innovator With Asymmetric Upside  Seeking Alpha

Entrada Therapeutics: Cash-Rich Innovator With Asymmetric Upside - Seeking Alpha

Click here to get full coverage on Doctoral student Luke Gibbons gets honour - Graduate Studies - Trinity College Dublin

Doctoral student Luke Gibbons gets honour - Graduate Studies  Trinity College Dublin

Doctoral student Luke Gibbons gets honour - Graduate Studies - Trinity College Dublin

Click here to get full coverage on Showcase 2025 - Graduate Studies - Trinity College Dublin

Showcase 2025 - Graduate Studies  Trinity College Dublin

Showcase 2025 - Graduate Studies - Trinity College Dublin

Click here to get full coverage on OPPO Find X5 and Find X5 Pro get certified, here are the camera details - Pocketnow

OPPO Find X5 and Find X5 Pro get certified, here are the camera details  Pocketnow

OPPO Find X5 and Find X5 Pro get certified, here are the camera details - Pocketnow

Click here to get full coverage on Are These 3 Biotech Stocks Good Buys? - Entrepreneur

Are These 3 Biotech Stocks Good Buys?  Entrepreneur

Are These 3 Biotech Stocks Good Buys? - Entrepreneur

Click here to get full coverage on Hall set to become TRDA director - advocateanddemocrat.com

Hall set to become TRDA director  advocateanddemocrat.com

Hall set to become TRDA director - advocateanddemocrat.com

Click here to get full coverage on Postgraduate Teaching Awards 2024 - Graduate Studies - Trinity College Dublin

Postgraduate Teaching Awards 2024 - Graduate Studies  Trinity College Dublin

Postgraduate Teaching Awards 2024 - Graduate Studies - Trinity College Dublin

Click here to get full coverage on Nothing Phone (3a) secures TRDA certification ahead of launch - Gizmochina

Nothing Phone (3a) secures TRDA certification ahead of launch  Gizmochina

Nothing Phone (3a) secures TRDA certification ahead of launch - Gizmochina

Click here to get full coverage on Vivo’s Galaxy S25 Edge lookalike spotted on certification site with 5380mAh battery - Gizmochina

Vivo’s Galaxy S25 Edge lookalike spotted on certification site with 5380mAh battery  Gizmochina

Vivo’s Galaxy S25 Edge lookalike spotted on certification site with 5380mAh battery - Gizmochina

Click here to get full coverage on Azenta Announces the Election of Dipal Doshi to its Board of Directors - Finansavisen

Azenta Announces the Election of Dipal Doshi to its Board of Directors  Finansavisen

Azenta Announces the Election of Dipal Doshi to its Board of Directors - Finansavisen

Click here to get full coverage on Motorola Edge 50 Pro bags multiple certifications, including FCC, BIS and TRDA - Gizmochina

Motorola Edge 50 Pro bags multiple certifications, including FCC, BIS and TRDA  Gizmochina

Motorola Edge 50 Pro bags multiple certifications, including FCC, BIS and TRDA - Gizmochina

Click here to get full coverage on Motorola Edge 40: Certifications confirm various specifications and confirm global launch - Notebookcheck

Motorola Edge 40: Certifications confirm various specifications and confirm global launch  Notebookcheck

Motorola Edge 40: Certifications confirm various specifications and confirm global launch - Notebookcheck

Click here to get full coverage on ‘We Are Perplexed’: Kerala High Court Raises Alarm Over Tribal School Shifted to Human–Wildlife Conflict Zone - The Law Advice

‘We Are Perplexed’: Kerala High Court Raises Alarm Over Tribal School Shifted to Human–Wildlife Conflict Zone  The Law Advice

‘We Are Perplexed’: Kerala High Court Raises Alarm Over Tribal School Shifted to Human–Wildlife Conflict Zone - The Law Advice

Click here to get full coverage on Tripura CM Lauds Doctors’ “Immense” Contributions To Society At TRDA Conference - Northeast Today

Tripura CM Lauds Doctors’ “Immense” Contributions To Society At TRDA Conference  Northeast Today

Tripura CM Lauds Doctors’ “Immense” Contributions To Society At TRDA Conference - Northeast Today

Click here to get full coverage on POCO F4 spotted on TRDA certification site, global launch expected soon - Gizmochina

POCO F4 spotted on TRDA certification site, global launch expected soon  Gizmochina

TRDA

Price Chart

Key Statistics

Technicals

About TRDA

Latest News

TRDA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

HC Wainwright Issues Positive Forecast for TRDA Earnings - MarketBeat

TRDA: Four clinical readouts and pipeline expansion set up a pivotal 2026, driven by EEV technology - TradingView

Advanced Charts

Top Gainers

Top Losers